Use of statistical parametric mapping of 18F-FDG-PET in frontal lobe epilepsy

NuklearMedizin

Volumn 42, Issue 5, 2003, Pages 190-196

  Plotkin, M ^b   Amthauer, H ^c   Merschhemke, M ^a   Ludemann L ^c   Hartkop, E ^c   Ruf, J ^c   Gutberlet, M ^c   Bertram, H ^c   Meencke, H J ^a   Felix, R ^c   Venz, St ^c  

^a Königin Elisabeth Herzberge Hospital   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NONE

Author keywords

Fluorine 18 Fluorodeoxyglucose; Frontal lobe epilepsy; Positron emission tomography; Statistical parametrical mapping

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FRONTAL LOBE EPILEPSY; HEMISPHERIC DOMINANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; SEIZURE;

EID: 10744231133     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625189     Document Type: Article

References (42)

1. Abou Khalil BW, Siegel BW, Sackellares GJ et al. Positron emission tomography studies of cerebral glucose metabolism in chronic partial epilepsy. Ann Neurol 1987; 22: 480-6.
2. Bartenstein P, Grunwald F, Kuwert T et al. Clinical applications of single photon emission tomography in neuromedicine. 1. Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease. Nuklearmedizin 2000; 39: 180-95.
3. Cascino GD, Jack CRJr, Parisi JE et al. MRI in the presurgical evaluation of patients with frontal lobe epilepsy and children with temporal lobe epilepsy: pathologic correlation and prognostic importance. Epilepsy Res 1992; 11: 51-9.
4. Chavauve P. Semiologie der Frontallappenanfälle. In: Wolf P (ed). Epilepsie. Reinbek: Einhorn-Presse Verlag 1989; 89: 26-34.
5. da Silva EA, Chugani DC, Muzik O et al. Identification of frontal lobe epilepsy foci in children using positron emission tomography. Epilepsia 1997; 38: 1198-208.
6. Engel J Jr, Henry TR, Swartz BE. Positron emission tomography in frontal lobe epilepsy. Adv Neurol 1995; 66: 223-38.
7. Engel J Jr, Kuhl DE, Phleps ME et al. Interictal cerebral glucose metabolism in partial epilepsy and its relation to EEG changes. Ann Neurol 1982; 12: 510-7.
8. Engel J Jr., Henry TR., Risinger MW et al. Presurgical evaluation for partial epilepsy: relative contributions of chronic depth-electrode recordings versus FDG-PET and scalp-sphenoidal ictal EEG. Neurology 1990; 40: 1670-7.
9. Engel J, van Ness PC, Rasmussen TB et al. Outcome with respect to epileptic seizures. In: Engel J Jr (ed). Surgical treatment of the epilepsies. New York: Raven Press 1993; 609-21.
10. Evans AC, Collins DL, Mills SR et al. 3D statistical neuroanatomical models from 305 MRI volumes. Proc IEEE Nuc Sci Symp Med Imag 1993; 1813-7.
11. Fiestel H, Weis M, Michalik K et al. SPECT bei Anfallsleiden. Der Nuklearmediziner 1997; 20: 81-105.
12. Hajek M, Antonioni A, Leenders KL et al. Mesiobasal versus lateral temporal lobe epilepsy: Metabolic differences in the temporal lobe shown by interictal 18F-FDG positron emission tomography. Neurology 1993; 43: 79-86.
13. 11C]-flumazenil PET in mesial temporal lobe epilepsy. Neurology 2001; 56: 897-906.
14. Harvey AS, Hopkins IJ, Nowe JM et al. Frontal lobe epilepsy: clinical seizure characteristics and localization with ictal 99mTc-HMPAO SPECT. Neurology 1993; 43: 1966-80.
15. Henry TR, Engel J Jr, Mazziotta JC. Clinical evaluation of interictal fluorine-18-fluorodeoxyglucose PET in partial epilepsy. J Nucl Med 1993; 34: 1892-8.
16. Henry TR, Mazziotta JC, Engel J Jr et al. Quantifying interictal metabolic activity in human temporal lobe epilepsy. J Cereb Blood Flow Metab 1990; 10: 748-57.
17. Henry TR, Sutherling WW, Engel J Jr et al. Interictal cerebral metabolism in partial epilepsies of neocortical origin. Epilepsy Res 1991; 10: 174-8.
18. Jobst BDC, Siegel AM, Thadani VM et al. Intractable seizures of frontal lobe origin: clinical characteristics, localizing signs, and results of the surgery. Epilepsia 2000; 41: 1139-52.
19. Kennedy AM, Newman SK, Frackowiak RS et al. Chromosome 14 linked familial Alzheimer's disease: a clinicopathological study of a single pedigree. Brain 1995; 118: 185-205.
20. 18F-FDG PET in localization of frontal lobe epilepsy: comparison of visual and SPM analysis. J Nucl Med 2002; 43: 1167-74.
21. 11C-flumazenil PET in patients with refractory temporal lobe epilepsy and normal MRI. Neurology 2000; 54: 332-9.
22. Lee JD, Kim HJ, Lee BI et al. Evaluation of ictal brain SPET using statistical parametric mapping in temporal lobe epilepsy. Eur J Nucl Med 2000; 27: 1658-65.
23. Lorenzo NY, Parisi JE, Cascino GD et al. Intractable frontal 10obe epilepsy: pathological and MRI features. Epil res 1995; 20:171-8.
24. Matheja P, Ludemann P, Kuwert T et al. Disturbed benzodiazepine receptor function at the onset of temporal lobe epilepsy - Iomazenil-binding in de-novo TLE. J Neurol 2001; 248: 585-91.
25. Mihara T, Matsuda K, Tottori T et al. Focal cortical dysplasia and epilepsy surgery. No To Hattatsu 1997; 29: 134-44.
26. Mosewic RK, So EL, O'Brien TJ et al. Factors predictive of the outcome of frontal lobe epilepsy surgery. Epilepsia 2000; 41: 843-9.
27. Muzik O, Chugani C, Juhász C et al. Statistical parametric mapping: assessment of application in children. Neuroimage 2000; 12: 538-49.
28. Plotkin M, Amthauer H, Lüdemann L et al. Statistical parametrical mapping of cerebral glucose metabolism in frontal lobe epilepsy. Eur J Nucl Med 2002; 29: 92.
29. Podreka I, Lang W, Suess E et al. Hexa-methylpropilene-amine-oxime (HMPAO) single photon emission computed tomography (SPECT) in epilepsy. Brain Topogr 1988; 1: 55-60.
30. Rubin E, Dhawan V, Moeller JR et al. Cerebral metabolic topography in unilateral temporal lobe epilepsy. Nerology 1995; 45: 2212-23.
31. 18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. Brain 1998; 121: 2067-81.
32. Salloway SP. Diagnosis and treatment of patients with "frontal lobe" syndromes. J Neuropsychiatry Clin Neurosci 1994; 6: 388-98.
33. 11C]-flumazenil positron emission tomography visualises frontal epileptogenic regions. Epilepsia 1995; 12: 1225-32.
34. 18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 1999; 9: 63-80.
35. Spencer SS, Spenser DD, Williamson PD et al. The localizing value of depth electroencephalography in 32 patients with refractory epilepsy. Ann Neurol 1982; 12: 248-53.
36. Stefan H, Pawlik G, Bocher-Schwarz HG et al. Functional and morphological abnormalities in temporal lobe epilepsy: a comparison of interictal and ictal EEG, CT, MRI, SPECT and PET. J Neurol 1987; 234: 377-84.
37. Swartz BE, Halgren E, Delgado-Escueta AQV et al. Neuroimaging in patients with seizure of probable frontal lobe origin. Epilepsia 1989; 30: 547-8.
38. Theodore WH, Fishbein D, Dubinsky R. Patterns of cerebral glucose metabolism in patients with partial seizures. Neurology 1988; 38: 1201-6.
39. Valk PE, Laxer K, Barbaro NM et al. High-resolution (2.6 mm) PET in partial complex epilepsy associated with mesial temporal sclerosis. Radiology 1993; 186: 55-8.
40. Van Bogaert P, Massager N, Tugendhaft P et al. Statistical parametric mapping of regional glucose metabolism in mesial temporal lobe epilepsy. Neuroimage 2000; 12: 129-38.
41. 123I-iomazenil SPECT. Comparison with video/EEG monitoring and postoperative results. Nuklearmedizin 1994; 33: 189-93.
42. Willoch F, Arnold S, Noachtar S et al. Die Positronenemissionstomographie in der präoperativen Epilepsiediagnostik. Der Nuklearmediziner 1997; 20: 107-13.